Investigators conducted a systematic review and meta-analysis of 37 studies that used a test-negative design to evaluate IVE against influenza-associated hospitalization in children.
Investigators compared the immunogenicity and safety of the influenza vaccine of different intradermal vaccine doses with a standard intramuscular dose.
Researchers used Medicare claims data to estimate differences in influenza vaccination rates among patients of female vs male physicians.
Researchers assessed the impact on pooled adjusted end-season vaccine effectiveness estimates from outpatient test-negative design studies.
Flucelvax Quadrivalent is a subunit influenza vaccine manufactured using cell derived candidate vaccine viruses; it does not contain egg proteins or antibiotics.
Researchers compared safety, reactogenicity, and changes in Health-Related Quality of Life scores of aIIV3 vs HD-IIV3 flu vaccines in older adults.
Researchers analyzed pooled patient data from 2 hospital-based respiratory virus surveillance cohorts to assess the burden of noninfluenza respiratory virus (NIRV) infection.
Researchers compared respiratory viral infections other than severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020 to corresponding periods in the previous 5 years.
In December 2020, researchers conducted a survey of 1027 adults to determine percentage of those receiving, or intending to receive, influenza vaccination.
The objective of this quasi-experimental observational study was to measure the effect of states’ hospital worker influenza vaccination laws on pneumonia and influenza mortality.
